# Belgaum Turmeric (Curcuma longa)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/belgaum-turmeric
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Curcuma longa L., Karnataka Belgaum turmeric, Belgaum district turmeric, Indian turmeric Belgaum variety

## Overview

Belgaum Turmeric is a cultivar of Curcuma longa grown in the Karnataka region of India, valued agriculturally for its high-yielding traits and potential curcuminoid content including curcumin, demethoxycurcumin, and bisdemethoxycurcumin. No cultivar-specific clinical research has isolated Belgaum Turmeric's effects from broader Curcuma longa data, making evidence-based health claims for this variant premature.

## Health Benefits

• No specific health benefits documented for Belgaum Turmeric cultivar (evidence quality: absent)
• General Curcuma longa benefits cannot be confirmed for this specific variant without cultivar-specific research
• High-yielding genotypes noted for potential curcuminoid content, though concentrations unspecified
• Traditional medicinal uses referenced for Curcuma longa species but not verified for Belgaum variant
• No clinical trials available to support health claims for this specific cultivar

## Mechanism of Action

Curcumin, the primary polyphenol in Curcuma longa cultivars including Belgaum Turmeric, inhibits NF-κB signaling by blocking IκB kinase (IKK) activation, thereby reducing transcription of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s such as TNF-α, IL-1β, and IL-6. Curcumin also modulates the Nrf2-Keap1 pathway, upregulating [antioxidant](/ingredients/condition/antioxidant) response elements and enzymes like heme oxygenase-1 (HO-1) and [glutathione](/ingredients/condition/detox)-S-transferase. However, these mechanisms are established for curcumin generally and have not been confirmed in assays using Belgaum-specific cultivar extracts with verified curcuminoid concentrations.

## Clinical Summary

No randomized controlled trials or observational studies have been conducted specifically on Belgaum Turmeric as a distinct cultivar. General Curcuma longa research includes trials on standardized curcumin extracts (typically 500–1000 mg/day) showing modest reductions in CRP and IL-6 in populations with metabolic syndrome and osteoarthritis, but these cannot be extrapolated to Belgaum Turmeric without confirmed curcuminoid profiling of this cultivar. Agricultural studies from India have noted Belgaum-type genotypes among high-yielding accessions, but curcuminoid percentages specific to this cultivar remain inconsistently reported. The overall evidence base for Belgaum Turmeric as a distinct therapeutic ingredient is currently absent.

## Nutritional Profile

Belgaum Turmeric (Curcuma longa) is a regional cultivar grown predominantly in the Belgaum (Belagavi) district of Karnataka, India. While cultivar-specific compositional analyses are limited, its nutritional profile can be reasonably estimated based on general Curcuma longa rhizome data and regional agronomic reports noting it as a high-yielding genotype. **Macronutrients (per 100 g dry weight, approximate):** • Carbohydrates: 60–70 g (primarily starch, ~40–50 g; dietary fiber ~18–25 g, of which soluble fiber ~2–5 g) • Protein: 6–9 g (contains notable levels of glutamic acid, aspartic acid, and leucine) • Fat: 5–10 g (predominantly oleic acid, palmitic acid, linoleic acid; volatile oil fraction ~3–5% contributing aromatic terpenoids such as ar-turmerone, turmerone, and zingiberene) • Moisture (fresh rhizome): 75–85%; dry powder typically ≤10%. **Curcuminoids (primary bioactive compounds):** • Total curcuminoid content estimated at 2–5% of dry weight, though Belgaum cultivar-specific concentrations remain unconfirmed in peer-reviewed literature. Breakdown typically: – Curcumin (diferuloylmethane): ~60–75% of total curcuminoids (~1.5–3.5 g/100 g dry weight) – Demethoxycurcumin: ~15–25% of total curcuminoids – Bisdemethoxycurcumin: ~5–15% of total curcuminoids • Bioavailability of curcuminoids is inherently low (<1% oral absorption) due to rapid hepatic [metabolism](/ingredients/condition/weight-management) and poor aqueous solubility; co-administration with piperine (from black pepper) may enhance bioavailability by ~2000%. **Minerals (per 100 g dry weight, approximate):** • Potassium: 2000–2500 mg • Iron: 40–55 mg (non-heme; bioavailability ~5–12%, enhanced by vitamin C co-ingestion) • Manganese: 15–25 mg • Calcium: 150–200 mg • Magnesium: 190–250 mg • Phosphorus: 250–300 mg • Zinc: 4–5 mg • Copper: 0.5–1.0 mg • Sodium: 30–40 mg • Selenium: trace amounts (~4–6 µg). **Vitamins (per 100 g dry weight, approximate):** • Vitamin C (ascorbic acid): 25–30 mg (degrades significantly during drying/processing) • Vitamin B6 (pyridoxine): 1.5–2.0 mg • Niacin (B3): 4–5 mg • Riboflavin (B2): 0.2–0.3 mg • Folate (B9): ~20–40 µg • Vitamin E (tocopherols): 3–4 mg • Vitamin K: ~13–14 µg • Vitamin A: minimal, though yellow pigmentation is due to curcuminoids, not carotenoids. **Other Bioactive Compounds:** • Essential/volatile oils: 3–5% (ar-turmerone ~25–35% of oil, α-turmerone ~18–25%, β-turmerone ~12–18%, zingiberene ~5–8%, α-phellandrene, 1,8-cineole, sabinene in smaller fractions) • Polysaccharides (ukonan A, B, C, D): [immunomodulatory](/ingredients/condition/immune-support) arabinogalactans, concentrations not well-quantified for this cultivar • Peptides: turmerin (~0.1% of dry weight), a water-soluble [antioxidant](/ingredients/condition/antioxidant) peptide • Phenolic acids: ferulic acid, caffeic acid, vanillic acid in minor concentrations (~0.01–0.1%) • Resin content: ~5–8%. **Bioavailability Notes:** The lipophilic nature of curcuminoids limits gastrointestinal absorption. The volatile oil fraction (particularly turmerones) present in whole turmeric may modestly improve curcumin bioavailability compared to isolated curcumin extracts. Fat-soluble compounds benefit from consumption with dietary lipids. The high fiber content may influence mineral absorption through phytate interactions, though turmeric is typically consumed in small culinary quantities (2–5 g/day), making absolute nutrient contributions modest in practical dietary contexts. **Caveat:** No cultivar-specific nutritional analysis for Belgaum Turmeric has been identified in published literature. Values are extrapolated from general Curcuma longa composition data and should be interpreted cautiously pending cultivar-specific verification.

## Dosage & Preparation

No clinically studied dosage ranges are available for Belgaum Turmeric. Standard forms, extracts, or standardization details have not been established through research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Curcuma longa preparations are generally recognized as safe at culinary doses, but concentrated curcumin supplements at 4–8 g/day have been associated with gastrointestinal disturbances including nausea, diarrhea, and increased [intestinal permeability](/ingredients/condition/gut-health) in some individuals. Curcumin inhibits CYP3A4 and CYP2C9 enzyme activity, potentially elevating plasma levels of drugs such as warfarin, tacrolimus, and certain statins, requiring caution with concurrent use. High-dose curcumin is not recommended during pregnancy due to its potential to stimulate uterine contractions, and individuals with gallstones or bile duct obstruction should avoid concentrated turmeric supplements as curcumin increases bile production. Because Belgaum Turmeric lacks a defined standardized extract, actual curcuminoid dose delivered per serving is uncertain, complicating safety guidance.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Belgaum Turmeric were found in the research dossier. The provided sources focus solely on agricultural cultivation practices without any PMIDs or clinical evidence for this cultivar variant.

## Historical & Cultural Context

Curcuma longa has been historically used as a condiment for coloring, flavoring, and medicinal purposes. However, no specific traditional medicine systems or indications are documented for the Belgaum cultivar variant in the available sources.

## Synergistic Combinations

Insufficient research to recommend synergistic ingredients

## Frequently Asked Questions

### What makes Belgaum Turmeric different from other turmeric varieties?

Belgaum Turmeric is a regional cultivar of Curcuma longa cultivated in the Belgaum (Belagavi) district of Karnataka, India, and is noted in agricultural literature for high rhizome yield per hectare. The distinction between cultivars typically lies in curcuminoid concentration, essential oil profile, and rhizome morphology, but no published phytochemical fingerprint uniquely characterizes the Belgaum cultivar versus widely studied types like Alleppey or Madras. Without standardized extraction data, its differentiation from other Curcuma longa cultivars remains agronomic rather than pharmacological.

### How much curcumin does Belgaum Turmeric contain?

Curcuminoid content in Curcuma longa rhizomes generally ranges from 2% to 9% dry weight across cultivars, with curcumin comprising approximately 77% of that fraction alongside demethoxycurcumin and bisdemethoxycurcumin. Specific curcuminoid quantification for the Belgaum cultivar has not been consistently published in peer-reviewed literature, so its potency relative to standardized commercial turmeric cannot be confirmed. Consumers relying on Belgaum Turmeric for therapeutic curcumin intake should seek products with third-party verified curcuminoid percentages.

### Is there clinical research specifically on Belgaum Turmeric?

As of the current evidence review, no published clinical trials — including randomized controlled trials, pilot studies, or case series — have been conducted using Belgaum Turmeric as a specifically identified and characterized test material. Research on Curcuma longa health effects uses standardized extracts such as BCM-95, Meriva, or Theracurmin, none of which are derived from or attributed to the Belgaum cultivar. Any health benefits attributed to Belgaum Turmeric are therefore inferred from general turmeric research and should be interpreted cautiously.

### Can Belgaum Turmeric help with inflammation?

General Curcuma longa extracts have demonstrated anti-inflammatory activity in human trials by reducing serum CRP levels by approximately 0.35–1.5 mg/L and lowering IL-6 concentrations in subjects with conditions including rheumatoid arthritis and metabolic syndrome, primarily at standardized curcumin doses of 500–1000 mg/day. Whether Belgaum Turmeric delivers equivalent curcuminoid levels to replicate these outcomes is unknown without cultivar-specific phytochemical analysis. Until such data are published, claiming anti-inflammatory efficacy for Belgaum Turmeric specifically would be unsupported.

### What is the recommended dosage for Belgaum Turmeric supplements?

No cultivar-specific dosage guidelines exist for Belgaum Turmeric because it has not been evaluated in clinical pharmacokinetic or dose-finding studies. General turmeric root powder is consumed at 1–3 g/day in culinary contexts, while standardized curcumin extracts used in clinical research range from 180 mg/day (nanoparticle formulations like Theracurmin) to 1500 mg/day (phospholipid complexes like Meriva). Bioavailability of native curcumin is poor (less than 1% oral absorption), and without formulation-specific data for Belgaum Turmeric products, effective dosing cannot be established.

### Is Belgaum Turmeric safe to take with blood thinners or antiplatelet medications?

Curcuma longa, including Belgaum varieties, may have mild anticoagulant properties that could theoretically interact with blood thinners like warfarin or aspirin. There is limited cultivar-specific safety data for Belgaum Turmeric, so consultation with a healthcare provider is essential before combining it with antiplatelet or anticoagulant drugs. Individual responses vary based on dosage and overall health status.

### Is Belgaum Turmeric safe during pregnancy and breastfeeding?

Safety data specific to Belgaum Turmeric during pregnancy and lactation is not well-established in clinical literature. While traditional use of Curcuma longa exists in some cultures, high-dose supplementation is generally not recommended during pregnancy without medical supervision due to potential uterotonic effects. Breastfeeding mothers should consult healthcare providers before supplementing with any turmeric cultivar.

### Which turmeric form—Belgaum powder, extract, or standardized curcuminoid product—offers the best absorption?

Standardized extracts and curcuminoid concentrates generally offer superior bioavailability compared to raw powder, though no clinical studies specifically compare absorption rates of Belgaum versus other turmeric variants. Adding black pepper (piperine) or fat to any turmeric form enhances curcumin absorption by 20-fold, regardless of cultivar origin. The most bioavailable Belgaum products are typically those with standardized curcuminoid content and enhanced delivery systems.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*